MTOR and nonpapillary renal cell carcinoma: Taken together, these results validated that ALDH9A1 exerted tumor suppressor role and metabolic reprogramming role by repressing the expression of IQGAP2 and activating the AKT-mTOR-SREBP1 pathway in ccRCC.